Cargando…
Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors without effective diagnostic biomarkers. This study intended to dynamically analyze serum proteomics in different pathological stages of liver diseases, and discover potential diagnostic biomarkers for early HCC. Patients with...
Autores principales: | Guo, Jiao, Jing, Rui, Zhong, Jian-Hong, Dong, Xin, Li, Yun-Xi, Liu, Yin-Kun, Huang, Tian-Ren, Zhang, Chun-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617482/ https://www.ncbi.nlm.nih.gov/pubmed/28977922 http://dx.doi.org/10.18632/oncotarget.18782 |
Ejemplares similares
-
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
iTRAQ and PRM-based quantitative proteomics in early recurrent spontaneous abortion: biomarkers discovery
por: Cui, Ying, et al.
Publicado: (2019) -
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
por: Ikeda, Daiki, et al.
Publicado: (2013) -
Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
por: Zhang, Jinyan, et al.
Publicado: (2018)